Nalaganje...
Syk and tired of current chronic GVHD therapies
In this issue of Blood, Flynn et al(1) provide key data that lend further support to the development of clinical trials of spleen tyrosine kinase (Syk) inhibition for more effective chronic graft-versus-host disease (cGVHD) treatment.
Shranjeno v:
| izdano v: | Blood |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4481589/ https://ncbi.nlm.nih.gov/pubmed/26113534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-05-640672 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|